Dr. Lerwill is co-director of the Breast Pathology Service at Massachusetts General Hospital. She lectures in graduate medical education courses in the United States and abroad.
- Centers & Specialties
- Clinical Interests
- Breast pathology
- Gynecologic pathology
- Medical Education
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Board Certifications
- Anatomic Pathology
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Dr. Melinda Lerwill received her B.A. from Johns Hopkins University and her M.D. summa cum laude from Harvard Medical School. She completed her residency training in Anatomic Pathology and her fellowship training in Breast and Gynecological Pathology at Massachusetts General Hospital. Dr. Lerwill is an Associate Pathologist at Massachusetts General Hospital, where she is director of the breast pathology service and breast pathology fellowship. She is an Assistant Professor of Pathology at Harvard Medical School. Dr. Lerwill is a frequent lecturer at national and international post-graduate courses. She has authored chapters on breast and gynecologic pathology in several major textbooks, including Rosen's Breast Pathology, Blaustein's Pathology of the Female Genital Tract, and Sternberg's Diagnostic Surgical Pathology. Her academic interests focus on early neoplasia of the breast, biphasic tumors of the breast, metastatic lesions to the gynecological tract, and graduate medical education.
- Research Summary
Current areas of clinicopathologic investigation include:
Early epithelial neoplasia of the breast
Phyllodes tumors and other biphasic lesions of the breast
Use of immunohistochemistry as a diagnostic aid in breast pathology
Metastatic tumors to the ovary
- Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy. Moy B, Specht MC, Lanuti M, Rafferty EA, Lerwill MF. N Engl J Med. 2015 Jan 8;372(2):162-70. doi: 10.1056/NEJMcpc1408601. No abstract available.
- Computational pathology to discriminate benign from malignant intraductal proliferations of the breast. Dong F, Irshad H, Oh EY, Lerwill MF, Brachtel EF, Jones NC, Knoblauch NW, Montaser-Kouhsari L, Johnson NB, Rao LK, Faulkner-Jones B, Wilbur DC, Schnitt SJ, Beck AH. PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.
- Case records of the Massachusetts General Hospital. Case 17-2011. A 49-year-old woman with a mass in the breast and overlying skin changes. Overmoyer BA, Lee JM, Lerwill MF. N Engl J Med. 2011 Jun 9;364(23):2246-54. doi: 10.1056/NEJMcpc1100922. No abstract available.
55 Fruit Street
Boston, MA 02114-2696